文献速递甲状腺疾病

高危RET突变预后差异:遗传性甲状腺髓样癌中C634R与其他C634突变的结局比较

Do Prognostic Differences Exist Among High-Risk RET Mutations? A Comparison of Outcomes Between the RET C634R and Other C634 Mutations in Hereditary Medullary Thyroid Carcinoma.
PubMed 文献 · Thyroid · 2025-09-03

这项国际多中心回顾性队列研究纳入317例携带RET密码子634突变的遗传性甲状腺髓样癌患者,比较C634R与其他C634突变的侵袭性与长期结局。中位随访10.6年,C634R组原发肿瘤更大、淋巴结转移和腺外侵犯更早更频繁,且与远处转移及更差疾病特异性生存显著相关。

要点

  • C634R突变者原发肿瘤更大,淋巴结转移和腺外侵犯累积率更高、发生更早。
  • C634R突变与远处转移风险升高独立相关(HR 2.545)。
  • C634R基因型、年龄增长和腺外侵犯与更差疾病特异性生存独立相关。

核心结论

  • 在遗传性甲状腺髓样癌中,RET C634R突变较其他C634突变侵袭性更强,疾病特异性生存更差。

研究设计与样本

  • 国际多中心回顾性队列研究,纳入三个三级医疗中心治疗的317例携带RET密码子634突变的遗传性甲状腺髓样癌患者(C634R 133例,C634F/G/S/W/Y 184例),来自137个家系,中位随访10.6年(4.9-16.6年)。

主要发现

  • C634R组初次手术年龄略年轻(27.8 ± 12.1 vs. 31.3 ± 14.9,p = 0.025),原发肿瘤更大(1.9 ± 1.2 vs. 1.5 ± 1.1,p = 0.006)。
  • Kaplan-Meier分析显示C634R组淋巴结转移(p = 0.0003)和腺外侵犯(p < 0.0001)的累积率显著更高且发生更早。
  • C634R突变与远处转移显著相关(HR 2.545 [CI 1.134-5.713];p = 0.024)。
  • 多变量分析显示RET C634R基因型(HR 6.488 [CI 1.364-30.862];p = 0.019)、年龄增长(HR 1.082 [CI 1.023-1.144];p = 0.006)和腺外侵犯(HR 9.695 [CI 2.344-40.105];p = 0.002)与更差疾病特异性生存显著相关。

临床怎么用

  • 对携带RET C634R突变的遗传性甲状腺髓样癌患者,应认识到其更高侵袭性和更差生存风险,考虑更密切的监测和积极管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The American Thyroid Association has stratified RET C634 mutations as high risk. The association between RET C634R mutation and a more aggressive medullary thyroid carcinoma (MTC) behavior compared with other C634 mutations remains inconclusive, possibly due to the lack of large cohorts and long-term outcome data. This study aimed to evaluate the aggressiveness and long-term outcomes of hereditary MTC in patients with different RET codon 634 mutations. Methods: This study is an international, multicenter, retrospective cohort study. Data from patients with hereditary MTC carrying RET codon 634 mutations treated at three tertiary medical centers were retrospectively analyzed. Clinicopathological features and long-term outcomes were compared between patients with the C634R and those with other C634 mutations (C634F/G/S/W/Y). Results: The study cohort included 317 patients (C634R: 133; C634F/G/S/W/Y: 184) from 137 families with a median follow-up of 10.6 years (4.9-16.6 years). Patients with the C634R mutation were slightly younger at the time of initial surgery (27.8 ± 12.1 vs. 31.3 ± 14.9, p = 0.025). Meanwhile, the C634R group showed larger primary tumors (1.9 ± 1.2 vs. 1.5 ± 1.1, p = 0.006). Kaplan-Meier analysis revealed significantly higher cumulative rates and earlier occurrence of lymph node metastases (p = 0.0003) and extrathyroidal extension (ETE; p < 0.0001) in the C634R group. The C634R mutation was significantly associated with distant metastases (hazard ratio [HR]: 2.545 [confidence interval (CI) 1.134-5.713]; p = 0.024). Moreover, multivariable analysis identified RET C634R genotype (HR: 6.488 [CI 1.364-30.862]; p = 0.019), increasing age (HR: 1.082 [CI 1.023-1.144]; p = 0.006), and ETE (HR: 9.695 [CI 2.344-40.105]; p = 0.002) to be significantly associated with worse disease-specific survival. Conclusions: Prognosis varied in hereditary MTC patients with RET C634 mutations. Our data highlight that the RET C634R mutation was associated with greater tumor aggressiveness in MTC and a poorer disease-specific survival.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Zhang J, Castroneves LA, Lindsey SC, et al. Do Prognostic Differences Exist Among High-Risk RET Mutations? A Comparison of Outcomes Between the RET C634R and Other C634 Mutations in Hereditary Medullary Thyroid Carcinoma. Thyroid. 2025. PMID: 40897504. doi:10.1177/10507256251372196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。